Yousif Capital Management LLC Grows Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Yousif Capital Management LLC grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 0.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 343,445 shares of the pharmacy operator’s stock after acquiring an additional 1,289 shares during the quarter. Yousif Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $8,967,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in WBA. Dark Forest Capital Management LP increased its holdings in shares of Walgreens Boots Alliance by 6.5% in the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock valued at $654,000 after acquiring an additional 1,804 shares during the period. Deutsche Bank AG grew its stake in Walgreens Boots Alliance by 36.2% in the third quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock valued at $48,269,000 after purchasing an additional 576,534 shares during the last quarter. Van ECK Associates Corp grew its position in shares of Walgreens Boots Alliance by 28.2% in the 3rd quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock worth $2,873,000 after buying an additional 28,400 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Walgreens Boots Alliance by 3.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator’s stock worth $32,130,000 after purchasing an additional 47,071 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.1 %

Shares of WBA opened at $17.80 on Thursday. Walgreens Boots Alliance, Inc. has a 52 week low of $17.51 and a 52 week high of $35.38. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $15.36 billion, a price-to-earnings ratio of -2.54, a PEG ratio of 1.12 and a beta of 0.73. The stock’s 50-day moving average price is $20.19 and its 200-day moving average price is $21.84.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same quarter in the prior year, the firm posted $1.16 EPS. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Wall Street Analysts Forecast Growth

WBA has been the topic of several analyst reports. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Bank of America dropped their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research note on Tuesday, March 26th. UBS Group dropped their price target on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. HSBC reissued a “reduce” rating and set a $20.00 target price (down previously from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Finally, Barclays started coverage on shares of Walgreens Boots Alliance in a report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price objective on the stock. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $24.36.

Read Our Latest Stock Analysis on WBA

Insider Transactions at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari bought 3,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders have bought a total of 13,456 shares of company stock valued at $270,423 in the last ninety days. 17.40% of the stock is currently owned by corporate insiders.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.